Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Healthcare Regulatory Affairs Outsourcing Market

ID: MRFR/HC/6334-HCR
90 Pages
Vikita Thakur
Last Updated: April 06, 2026
Healthcare Regulatory Affairs Outsourcing Market Research Report: Size, Share, Trend Analysis By Service (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs), By End Users (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Service (USD Billion)
      1. 4.1.1 Regulatory Writing and Publishing
      2. 4.1.2 Regulatory Submissions
      3. 4.1.3 Clinical Trial Applications and Services Registrations
      4. 4.1.4 Regulatory Consulting and Legal Representation
      5. 4.1.5 Other Regulatory Affairs
    2. 4.2 Healthcare, BY End User (USD Billion)
      1. 4.2.1 Mid-Size Pharmaceutical Companies
      2. 4.2.2 Large Pharmaceutical Companies
      3. 4.2.3 Biotechnology Companies
      4. 4.2.4 Medical Device Companies
      5. 4.2.5 Food and Beverage Companies
    3. 4.3 Healthcare, BY Region (USD Billion)
      1. 4.3.1 North America
        1. 4.3.1.1 US
        2. 4.3.1.2 Canada
      2. 4.3.2 Europe
        1. 4.3.2.1 Germany
        2. 4.3.2.2 UK
        3. 4.3.2.3 France
        4. 4.3.2.4 Russia
        5. 4.3.2.5 Italy
        6. 4.3.2.6 Spain
        7. 4.3.2.7 Rest of Europe
      3. 4.3.3 APAC
        1. 4.3.3.1 China
        2. 4.3.3.2 India
        3. 4.3.3.3 Japan
        4. 4.3.3.4 South Korea
        5. 4.3.3.5 Malaysia
        6. 4.3.3.6 Thailand
        7. 4.3.3.7 Indonesia
        8. 4.3.3.8 Rest of APAC
      4. 4.3.4 South America
        1. 4.3.4.1 Brazil
        2. 4.3.4.2 Mexico
        3. 4.3.4.3 Argentina
        4. 4.3.4.4 Rest of South America
      5. 4.3.5 MEA
        1. 4.3.5.1 GCC Countries
        2. 4.3.5.2 South Africa
        3. 4.3.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 IQVIA (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 PAREXEL International (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Covance (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Charles River Laboratories (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medpace (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Wuxi AppTec (CN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Syneos Health (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 PPD (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 KCR (PL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY SERVICE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 CANADA MARKET ANALYSIS BY SERVICE
    6. 6.6 CANADA MARKET ANALYSIS BY END USER
    7. 6.7 EUROPE MARKET ANALYSIS
    8. 6.8 GERMANY MARKET ANALYSIS BY SERVICE
    9. 6.9 GERMANY MARKET ANALYSIS BY END USER
    10. 6.10 UK MARKET ANALYSIS BY SERVICE
    11. 6.11 UK MARKET ANALYSIS BY END USER
    12. 6.12 FRANCE MARKET ANALYSIS BY SERVICE
    13. 6.13 FRANCE MARKET ANALYSIS BY END USER
    14. 6.14 RUSSIA MARKET ANALYSIS BY SERVICE
    15. 6.15 RUSSIA MARKET ANALYSIS BY END USER
    16. 6.16 ITALY MARKET ANALYSIS BY SERVICE
    17. 6.17 ITALY MARKET ANALYSIS BY END USER
    18. 6.18 SPAIN MARKET ANALYSIS BY SERVICE
    19. 6.19 SPAIN MARKET ANALYSIS BY END USER
    20. 6.20 REST OF EUROPE MARKET ANALYSIS BY SERVICE
    21. 6.21 REST OF EUROPE MARKET ANALYSIS BY END USER
    22. 6.22 APAC MARKET ANALYSIS
    23. 6.23 CHINA MARKET ANALYSIS BY SERVICE
    24. 6.24 CHINA MARKET ANALYSIS BY END USER
    25. 6.25 INDIA MARKET ANALYSIS BY SERVICE
    26. 6.26 INDIA MARKET ANALYSIS BY END USER
    27. 6.27 JAPAN MARKET ANALYSIS BY SERVICE
    28. 6.28 JAPAN MARKET ANALYSIS BY END USER
    29. 6.29 SOUTH KOREA MARKET ANALYSIS BY SERVICE
    30. 6.30 SOUTH KOREA MARKET ANALYSIS BY END USER
    31. 6.31 MALAYSIA MARKET ANALYSIS BY SERVICE
    32. 6.32 MALAYSIA MARKET ANALYSIS BY END USER
    33. 6.33 THAILAND MARKET ANALYSIS BY SERVICE
    34. 6.34 THAILAND MARKET ANALYSIS BY END USER
    35. 6.35 INDONESIA MARKET ANALYSIS BY SERVICE
    36. 6.36 INDONESIA MARKET ANALYSIS BY END USER
    37. 6.37 REST OF APAC MARKET ANALYSIS BY SERVICE
    38. 6.38 REST OF APAC MARKET ANALYSIS BY END USER
    39. 6.39 SOUTH AMERICA MARKET ANALYSIS
    40. 6.40 BRAZIL MARKET ANALYSIS BY SERVICE
    41. 6.41 BRAZIL MARKET ANALYSIS BY END USER
    42. 6.42 MEXICO MARKET ANALYSIS BY SERVICE
    43. 6.43 MEXICO MARKET ANALYSIS BY END USER
    44. 6.44 ARGENTINA MARKET ANALYSIS BY SERVICE
    45. 6.45 ARGENTINA MARKET ANALYSIS BY END USER
    46. 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE
    47. 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    48. 6.48 MEA MARKET ANALYSIS
    49. 6.49 GCC COUNTRIES MARKET ANALYSIS BY SERVICE
    50. 6.50 GCC COUNTRIES MARKET ANALYSIS BY END USER
    51. 6.51 SOUTH AFRICA MARKET ANALYSIS BY SERVICE
    52. 6.52 SOUTH AFRICA MARKET ANALYSIS BY END USER
    53. 6.53 REST OF MEA MARKET ANALYSIS BY SERVICE
    54. 6.54 REST OF MEA MARKET ANALYSIS BY END USER
    55. 6.55 KEY BUYING CRITERIA OF HEALTHCARE
    56. 6.56 RESEARCH PROCESS OF MRFR
    57. 6.57 DRO ANALYSIS OF HEALTHCARE
    58. 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    59. 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    60. 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
    61. 6.61 HEALTHCARE, BY SERVICE, 2024 (% SHARE)
    62. 6.62 HEALTHCARE, BY SERVICE, 2024 TO 2035 (USD Billion)
    63. 6.63 HEALTHCARE, BY END USER, 2024 (% SHARE)
    64. 6.64 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    65. 6.65 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.3.2 BY END USER, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.4.2 BY END USER, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.5.2 BY END USER, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.6.2 BY END USER, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.7.2 BY END USER, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.8.2 BY END USER, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.9.2 BY END USER, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.10.2 BY END USER, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.11.2 BY END USER, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.12.2 BY END USER, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.13.2 BY END USER, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.14.2 BY END USER, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.15.2 BY END USER, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.16.2 BY END USER, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.17.2 BY END USER, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.18.2 BY END USER, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.19.2 BY END USER, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.20.2 BY END USER, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.21.2 BY END USER, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.22.2 BY END USER, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.23.2 BY END USER, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.24.2 BY END USER, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.25.2 BY END USER, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.26.2 BY END USER, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.27.2 BY END USER, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.28.2 BY END USER, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.29.2 BY END USER, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.30.2 BY END USER, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Service (USD Billion, 2025-2035)

  • Regulatory Writing and Publishing
  • Regulatory Submissions
  • Clinical Trial Applications and Services Registrations
  • Regulatory Consulting and Legal Representation
  • Other Regulatory Affairs

Healthcare By End User (USD Billion, 2025-2035)

  • Mid-Size Pharmaceutical Companies
  • Large Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Food and Beverage Companies